Lead Optimization of 2-((4-fluorophenyl)(4-(pyrazin-2-yl)piperazin-1-yl)methyl)-6-methoxyphenol as GSK3β Inhibitors for Alzheimer’s Disease Therapeutics Targeting Tauopathy, and Neuroinflammation: In-silico design, Synthesis, and Biological Evaluation
Indian Institute Of Science, Karnataka
harimadhavgautam@gmail.com
Accessibility Controls